Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | UTHR |
---|---|---|
09:32 ET | 3135 | 274.62 |
09:34 ET | 200 | 273.39 |
09:36 ET | 833 | 274.84 |
09:38 ET | 656 | 275.73 |
09:39 ET | 200 | 275.35 |
09:41 ET | 600 | 275.46 |
09:45 ET | 500 | 275.96 |
09:48 ET | 100 | 275.96 |
09:50 ET | 200 | 276.46 |
09:52 ET | 300 | 276.67 |
09:54 ET | 900 | 277.23 |
09:56 ET | 2300 | 277.41 |
09:57 ET | 100 | 277.14 |
09:59 ET | 560 | 276.88 |
10:01 ET | 500 | 277.105 |
10:03 ET | 345 | 277.41 |
10:06 ET | 200 | 277.41 |
10:08 ET | 100 | 277.5 |
10:10 ET | 311 | 278.23 |
10:12 ET | 513 | 277.895 |
10:14 ET | 300 | 278.19 |
10:15 ET | 1100 | 277.4001 |
10:17 ET | 200 | 277.86 |
10:19 ET | 713 | 277.86 |
10:24 ET | 3057 | 277.89 |
10:26 ET | 100 | 277.985 |
10:28 ET | 1563 | 276.455 |
10:30 ET | 700 | 276.45 |
10:32 ET | 572 | 275.92 |
10:33 ET | 400 | 275.64 |
10:35 ET | 325 | 275.845 |
10:37 ET | 1180 | 275.12 |
10:39 ET | 500 | 274.56 |
10:44 ET | 995 | 275.24 |
10:46 ET | 1927 | 274.915 |
10:48 ET | 1634 | 274.55 |
10:51 ET | 200 | 274.695 |
10:53 ET | 1405 | 274.695 |
10:55 ET | 1412 | 274.32 |
10:57 ET | 800 | 274.2 |
11:00 ET | 388 | 273.625 |
11:02 ET | 1634 | 273.48 |
11:04 ET | 1175 | 274.03 |
11:08 ET | 200 | 273.6 |
11:09 ET | 200 | 273.63 |
11:11 ET | 100 | 274.025 |
11:15 ET | 800 | 274.02 |
11:18 ET | 1020 | 274.02 |
11:20 ET | 600 | 274.13 |
11:22 ET | 100 | 274.2 |
11:24 ET | 300 | 274.2 |
11:26 ET | 511 | 274.195 |
11:27 ET | 1717 | 274.075 |
11:29 ET | 5122 | 273.235 |
11:31 ET | 2909 | 273 |
11:33 ET | 3032 | 272.59 |
11:36 ET | 673 | 272.21 |
11:42 ET | 100 | 272.43 |
11:44 ET | 5076 | 272.885 |
11:45 ET | 300 | 273.255 |
11:51 ET | 600 | 273.38 |
11:54 ET | 100 | 273.135 |
11:56 ET | 300 | 273.135 |
11:58 ET | 300 | 273.09 |
12:00 ET | 1100 | 273.16 |
12:02 ET | 237 | 273.44 |
12:03 ET | 400 | 273.16 |
12:05 ET | 1811 | 272.855 |
12:07 ET | 200 | 272.915 |
12:09 ET | 300 | 272.895 |
12:12 ET | 1777 | 271.92 |
12:14 ET | 300 | 271.65 |
12:16 ET | 400 | 271.66 |
12:18 ET | 100 | 271.75 |
12:20 ET | 450 | 271.54 |
12:21 ET | 1390 | 272 |
12:23 ET | 1124 | 272.51 |
12:32 ET | 500 | 272.665 |
12:34 ET | 2214 | 272.895 |
12:36 ET | 414 | 272.8 |
12:38 ET | 1220 | 272.705 |
12:41 ET | 200 | 272.74 |
12:43 ET | 2001 | 272.38 |
12:45 ET | 300 | 272.375 |
12:48 ET | 110 | 272.15 |
12:50 ET | 600 | 272.025 |
12:52 ET | 900 | 271.76 |
12:54 ET | 1281 | 272.095 |
12:56 ET | 200 | 272.105 |
12:57 ET | 700 | 271.86 |
12:59 ET | 800 | 272.125 |
01:01 ET | 100 | 271.67 |
01:03 ET | 100 | 271.72 |
01:08 ET | 300 | 271.56 |
01:10 ET | 100 | 271.56 |
01:12 ET | 3365 | 272.315 |
01:14 ET | 884 | 272.33 |
01:15 ET | 700 | 272.33 |
01:19 ET | 576 | 272.625 |
01:24 ET | 1721 | 272.76 |
01:32 ET | 936 | 273.375 |
01:33 ET | 564 | 273.37 |
01:35 ET | 1215 | 273.245 |
01:37 ET | 208 | 273.04 |
01:39 ET | 100 | 273.215 |
01:42 ET | 500 | 273.05 |
01:44 ET | 2976 | 273.84 |
01:46 ET | 685 | 273.675 |
01:48 ET | 200 | 273.725 |
01:51 ET | 200 | 273.715 |
01:53 ET | 100 | 273.96 |
01:55 ET | 900 | 273.99 |
01:57 ET | 100 | 273.96 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
United Therapeutics Corp | 12.2B | 13.0x | +8.22% |
Biomarin Pharmaceutical Inc | 14.3B | 74.4x | --- |
Medpace Holdings Inc | 12.0B | 39.7x | +35.10% |
Neurocrine Biosciences Inc | 13.6B | 37.4x | +62.04% |
Beigene Ltd | 16.0B | -20.4x | --- |
Exact Sciences Corp | 8.4B | -33.1x | --- |
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.2B |
---|---|
Revenue (TTM) | $2.5B |
Shares Outstanding | 44.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.49 |
EPS | $21.13 |
Book Value | $127.23 |
P/E Ratio | 13.0x |
Price/Sales (TTM) | 4.9 |
Price/Cash Flow (TTM) | 11.0x |
Operating Margin | 50.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.